Key Market Indicators
Sales of beta blocking medicines in Slovenia are forecast to reach $14.4 million by 2026. This is an increase of 1.2% year-on-year from 2021's total of $13.6 million. Since 2012, the Slovene market has grown by 4.2% annually. In 2021, it was ranked 20th in the world, with Denmark ahead at $13.6 million. Italy, Canada, and Australia followed in 2nd, 3rd, and 4th place respectively.
